2016 Biometer Shows Strength in Early and Late Stage Deals but Cracks Beneath the Surface -
The 2016 BioMeter showed strength at both ends of the drug-development spectrum, with extremely strong results for ...more
The full-year 2015 BioMeter paints the picture of a strong year for biotechnology, but deeper analysis shows a cautionary trend. The average BioMeter value for the entire year across all transactions reporting up-front...more
On February 5, 2016, Morrison & Foerster secured a preliminary injunction on behalf of its client, National Abortion Federation (“NAF”), in National Abortion Federation v. Center for Medical Progress. The firm’s work on this...more
2/10/2016
/ Abortion ,
Anti-SLAPP ,
Confidentiality Agreements ,
Corporate Counsel ,
Credibility ,
Interlocutory Appeals ,
Irreparable Harm ,
Planned Parenthood ,
Preliminary Injunctions ,
Prior Restraint ,
Rule 8 ,
Young Lawyers